Announcements Trials
Browse Landscape

Phase

Phase 1 35Phase 2 25Phase NA 4Phase 3 3Phase 1/2 3Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Sarcoma, Ewing 1Renal Pelvis and Ureter Urothelial Carcinoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Nasopharyngeal Carcinoma 1Muscle Invasive Bladder Urothelial Carcinoma 1Mouth Neoplasms 1Melanoma 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lymphoid Interstitial Pneumonia 1Leukemia, Myeloid, Acute 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Extensive Stage Lung Small Cell Carcinoma 1Carcinoma, Squamous Cell 1Carcinoma 1Adenocarcinoma of Lung 1Adenocarcinoma Of Esophagus 1

Interventions

venetoclax 12Cytarabine 12Azacitidine 10Decitabine 8Daunorubicin 7Cyclophosphamide 7Busulfan 6fludarabine phosphate 5Idarubicin 5Gemtuzumab 5Thiotepa 3Stem Cell Transplantation 3Filgrastim 3Cyclosporine 3vosaroxin 2fludarabine 2Whole-Body Irradiation 2Tretinoin 2Sorafenib 2Radiotherapy 2Methylprednisolone 2Methotrexate 2Melphalan 2Injections 2Etoposide 2Cladribine 2CPX-351 2Antilymphocyte Serum 2Abatacept 2vedolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Leukemia, Myeloid, Acute × Specimen Handling × Clear all
NCT03701308 2026-01-21

Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
267 enrolled 11 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡